Trial
NCT01316146
Administration of T Lymphocytes for Hodgkin's Lymphoma and Non-Hodgkin's Lymphoma (CART CD30)
Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
The Methodist Hospital Research Institute; Baylor College of Medicine; Center for Cell and Gene Therapy, Baylor College of Medicine
Condition
Non-Hodgkin's Lymphoma
Intervention
CAR.CD30 T cells
Why stopped
Study never truly opened to accrual at UNC. Study and data were transfered to UNC as the IND for the study was transfered to UNC. IRB closed the study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-03-22